重症急性胰腺炎患者早期胃内pH值变化的临床意义

目的探讨SAP患者SIRS期胃内pH值变化的临床意义及质子泵抑制剂(PPI)对其的影响。方法对2005年1月至2006年11月间,发病时间≤48h的108例SAP患者,采用试纸法检测胃液pH值变化,观测SAP患者人院时及入院后72h平均胃内pH值及pH值>4、>6的时点数变化,并与APACHEⅡ评分及上消化道出血进行比较。将入院时pH值≤4的74例患者分为PPI持续(A组)和间断(B组)静脉输注两组,观察其胃内pH值的变化及与上消化道出血的关系。结果108例患者入院时平均胃内pH值与APACHEⅡ评分呈负相关(r=-0.433,P<0.05)。pH值≤4与>4的患者分别占68.52%与31.48%.上消化道出血的患者分别有12例与1例.差异显著(x~2=3.8774,P= 0.0489)。应用PPI后0～24h,A、B组平均胃内pH值分别为5.24±0.83与4.79±0.89,24～48h时分别为6.21±1.45与5.56±1.22,差异显著(t=2.2067、2.0888,P=0.0305、0.0403),而48～72h时分别为6.42±1.18、5.98±1.05,差异无意义(t=1.6884,P=0.0957)。72h内,A、B组胃内pH值>4的时点数分别为29.22±2.38、27.97±2.92,无显著差异(t=1.9590,P=0.0540),而>6的时点数分别为25.66±4.98、20.32±3.72,差异显著(t=5.2828,P=0.0000)。两组发生上消化道出血分别为1例与11例(x~2=5.7220,P=0.0168),差异有统计学意义。结论SAP患者早期胃内pH值的高低与病情严重度及上消化道出血发生的危险性高度相关,静脉持续输注PPI能更迅速地提高胃内pH值,并能有效维持高pH值状态,减少上消化道出血的发生。     

Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study

Catheter-related infections remain a significant cause of method failure in chronic peritoneal dialysis (PD) therapy. Given the increasing antibiotic resistance, such nonpharmacological strategies as local silver devices attract more interest. To establish whether a silver ring device (designed by Grosse-Siestrup in 1992) mounted onto the PD catheter and placed at the exit site at skin level is effective in preventing exit-site and other catheter-related infections, a prospective 12-month, multicenter, controlled study stratified by diabetes status was conducted. The study subjects were assessed by an extensive structured inventory, including a broad spectrum of control variables, such as age, body mass index (BMI), Staphylococcus aureus carrier status, catheter features, mode and quality of PD therapy, comorbidity, and psychosocial rehabilitation. Ten experienced German outpatient dialysis centers (seven adult, three pediatric) participated in the trial. All eligible patients (n=195) from the study area without catheter-related infections during the ascertainment period were included (incidental subjects undergoing PD therapy for at least 3 months). The main outcome measures were the occurrence of first exit-site infections (primary study end point), sinus tract/tunnel infection, and peritonitis. Ninety-seven patients were assigned to the silver ring and 98 patients to the control group. Baseline characteristics of age, sex, proportion of pediatric and incidental patients, S aureus carrier status, and other variables were similar in both groups. The incidence of infections in the silver ring group versus the control group was as follows: 23 of 97 versus 16 of 98 patients had exit-site infections, 12 of 97 versus 12 of 98 patients had sinus tract/tunnel infections, 16 of 97 versus 18 of 98 patients had peritonitis, respectively. Kaplan-Meier analysis for the probability of an infection-free interval showed no statistical difference (log-rank test) between the two groups. Displacement of the silver ring contributed to study termination in 6% of the study group patients, including two patients with catheter loss. Univariate analysis and multiple logistic regression identified younger age (<50 years), low serum albumin level (<35 g/L), number of previously placed PD catheters, short cuff-exit distance (<2 cm), and S aureus nasal carriage as risk factors for the development of exit-site infections. In conclusion, our study does not show any benefit of the silver ring in preventing catheter-related infections in PD patients. Thus, prevention of infection-related method failure in PD still has to rely on conventional antibiotic treatment strategies and less so on alternative methods.     

他克林的合成研究

目的：合成抗早老性痴呆药他克林。方法：以邻氨基苯甲酸为原料,经缩合,氯化,氨化反应,制得他克林,结果：每步反庆均经改进,总收率达40．7％,所得产品熔点,IR,^1HNMR光谱数据,与文献报道值一致。结论：本工艺路线方法简单,原料易得,易工业化生产。     

Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs

RATIONALE: Inhaled nitric oxide (iNO) can reverse neonatal pulmonary hypertension and bronchoconstriction and reduce proliferation of cultured arterial and airway smooth muscle cells. OBJECTIVES: To see if continuous iNO from birth might reduce pulmonary vascular and respiratory tract resistance (PVR, RE) and attenuate growth of arterial and airway smooth muscle in preterm lambs with chronic lung disease. METHODS: Eight premature lambs received mechanical ventilation for 3 weeks, four with and four without iNO (5-15 ppm). Four term lambs, mechanically ventilated without iNO for 3 weeks, served as additional control animals. MEASUREMENTS: PVR and RE were measured weekly. After 3 weeks, lung tissue was processed for quantitative image analysis of smooth muscle abundance around small arteries (SMart) and terminal bronchioles (SMtb). Radial alveolar counts were done to assess alveolar number. Endothelial NO synthase (eNOS) protein in arteries and airways was measured by immunoblot analysis. MAIN RESULTS: At study's end, PVR was similar in iNO-treated and untreated preterm lambs; PVR was less in iNO-treated preterm lambs compared with term control animals. RE in iNO-treated lambs was less than 40% of RE measured in preterm control animals. SMart was similar in iNO-treated and both groups of control lambs; SMtb in lambs given iNO was significantly less (approximately 50%) than in preterm control animals. Radial alveolar counts of iNO-treated lambs were more than twice that of preterm control animals. eNOS was similar in arteries and airways of iNO-treated preterm lambs compared with control term lambs. CONCLUSIONS: iNO preserves structure and function of airway smooth muscle and enhances alveolar development in preterm lambs with chronic lung disease.     

Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti- idiotype monoclonal antibodies

Tumor-specific anti-idiotype (anti-Id) monoclonal antibodies (MoAbs) to B-cell lymphomas have been administered to patients, resulting in significant clinical responses. However, clinical responses have been limited by the emergence of Id-negative lymphoma. To overcome the problem of tumor heterogeneity, we conducted a pilot evaluation of the safety and effectiveness of yttrium 90 (90Y)-labeled anti-Id and shared Id (sId) MoAbs in non-Hodgkin's B-cell lymphoma. Nine patients with relapsed B-cell lymphoma in whom tumor was successfully targeted with 111In-labeled anti-Id MoAb were treated with 90Y-labeled anti-Id MoAb. A total of 19 courses (one to four per patient) were administered using 1,000 to 2,320 mg unlabeled clearing MoAb and 10 to 54 mCi 90Y MoAb per patient. Two of nine patients had a complete response, one a partial response, three stable disease, and three disease progression. Time to progression varied from 1 to 12 months. Toxicities were predominately hematologic, and only one patient developed infection and required transfusion. At progression, three of five assessable patients had Id- positive lymphoma and two had Id-negative lymphoma. Human antimouse antibodies (HAMA) did not develop in the patients after treatment. 90Y anti-Id MoAbs demonstrated excellent in vivo stability, produced significantly tumor regression in three of nine patients, exhibited acceptable toxicities, and elicited no HAMA formation. Further investigation of repetitive, low-dose 90Y anti-Id and MoAb therapy is warranted; however, the advantages of a pan B MoAb may prove the latter to be the agent of choice for the radio immunotherapy of B-cell lymphoma.     

Presentation of Primary Open Angle Glaucoma (POAG) at Lions Sight First Eye Hospital in Blantyre,Malawi

Objective

Primary open angle glaucoma (POAG) is the most common type of glaucoma in Africa. We carried out a study to determine the clinical presentation pattern of patients with primary open angle glaucoma (POAG) at a tertiary hospital in Malawi.

Design

A cross-sectional study

Setting

Lions Sight First Eye Hospital—a major referral and teaching state eye hospital in Blantyre, Malawi

Subjects

Study participants were newly diagnosed POAG patients at specialist eye clinic during study period.

Results

A total of 60 POAG patients were recruited into the study. The mean age was 58.7 years (SD= 16.6, range 18 - 86). There were more male (44, 73.3%) than female (16, 27.7%) patients. The majority of patients (73%) presented one year after onset of visual symptoms. Twenty-six patients (43%) had unilateral blindness (visual acuity < 3/60; WHO classification), while nine patients (15%) presented with bilateral blindness. A vertical cup-to-disc ratio (CDR) of 0.8 or worse was seen in 92 eyes (79%). The mean intraocular pressure (IOP) reading was 35.5 mmHg (SD 13.30). Of the thirty-three eyes that successfully underwent visual field analysis, very advanced defects were recorded in 12 eyes (36%).

Conclusion

This study demonstrates delayed presentation and male predominance among POAG patients at a tertiary eye hospital in Malawi. Glaucoma intervention programmes should aim at identifying patients with treatable glaucoma with particular attention to women.     

运用模糊聚类方法分析中药微量元素含量与药效的关系

目的:不同中药中各种微量元素的含量数据离散,从含量数据上很难说明不同药物的药物相似性,故运用模糊分类方法研究药物微量元素含量与药物疗效的关系,验证其在药物功效的相似性及不同种类中药定量指标评价方面的作用。方法:实验于2005-10/2006-11在吉林省中医药管理局中药微量元素分析实验室完成。用原子吸收分光光度法检测合欢花、黄芪、石菖蒲、远志、山楂、银杏叶、人参、元肉、蒲黄、酸枣仁、苏木11种中药中钾、钠、钙、镁、铁、铬、镍、锰、铜、锌元素的含量,结合锌/铜比值、镁/钙比值,以数据极差法进行统计指标的标准化处理,以数量积法算出衡量被分类对象之间的相关系数,确定论域上的模糊矩阵。结果:相关系数r=0.50时,合欢花,石菖蒲,远志,人参,元肉,蒲黄,酸枣仁7种药物聚类相似;相关系数r=0.65时,合欢花,石菖蒲,元肉,蒲黄,酸枣仁5种药物聚类相似;r=0.75时,合欢花,石菖蒲,蒲黄3种药物聚类相似。研究还发现:药物中金属元素含量丰富,而且相关系数较大的药物,其药物疗效相似。结论:运用数学与化学计量学方法建立模糊聚类分析模型,可以把离散的数据标准化处理,确定论域上的模糊矩阵可以研究不同药物间的药效相似性,可以对不同种类的中药进行定量指标的明确评价。